Related Experiment Video
Updated: Dec 21, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Expression levels of candidate circulating microRNAs in pediatric tuberculosis
Kathirvel M1, Saranya S2, Mahadevan S1
1Department of Paediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) , Puducherry, India.
Abstract:
Tuberculosis (TB) is a preventable and curable disease, but increased mortality and morbidity associated with TB is one of the leading causes of deaths worldwide. MicroRNAs (miRNAs) are small, non-coding RNAs known to regulate the host immune response against TB. We investigated the expression profile of candidate circulating miRNAs, which could be used as a blood biomarker for the effective diagnosis of pediatric tuberculosis. A cross-sectional comparative study was conducted, including 30 children with active-TB and 30 healthy controls (HC) in a tertiary care hospital in Puducherry. We used the SYBR green-based miScript qRT-PCR assay to analyze the expression levels of miRNAs in plasma. Further, we used the receiver operating characteristic curve (ROC) to evaluate the diagnostic value of miRNAs. Active-TB included 25 (83.3%) pulmonary TB and 5 (16.7%) extrapulmonary TB cases. We found a significant upregulation of miR-21, miR-29a, miR-31, miR-155, and downregulation of miR-146a in children with active-TB compared to HC. The ROC analysis showed an excellent diagnostic value of miRNAs as follows: miR‑31> miR‑155> miR‑146a with AUC of (95% CI) miRNAs 0.978, 0.953, and 0.903, respectively. Altered circulating miRNA expression levels could be involved in the dysregulation of the host immune response to TB. The ROC analysis indicated that miRNAs miR-31, miR-155 and miR-146a could be effective diagnostic biomarkers for the detection of active-TB in children.
Insights
Specific microRNAs (miRNAs) in blood show promise as biomarkers for diagnosing pediatric tuberculosis (TB). Upregulated miR-31, miR-155, and downregulated miR-146a effectively identified active TB in children.
Area of Science:
- Biochemistry
- Immunology
- Pediatrics
Background:
- Tuberculosis (TB) remains a significant global health challenge, causing substantial mortality and morbidity.
- MicroRNAs (miRNAs) are crucial regulators of the host immune response, particularly in infectious diseases like TB.
Purpose of the Study:
- To identify circulating miRNAs as potential blood biomarkers for diagnosing active tuberculosis in children.
- To investigate the diagnostic accuracy of specific miRNAs in pediatric TB cases.
Main Methods:
- A cross-sectional study involving 30 children with active TB and 30 healthy controls.
- Quantitative real-time PCR (qRT-PCR) was used to analyze plasma miRNA expression levels.
- Receiver Operating Characteristic (ROC) curve analysis was employed to assess diagnostic performance.
Main Results:
- Significant differences in circulating miRNA expression were observed between active TB cases and healthy controls.
- Upregulation of miR-21, miR-29a, miR-31, and miR-155, and downregulation of miR-146a were noted in children with active TB.
- ROC analysis demonstrated excellent diagnostic potential for miR-31 (AUC 0.978), miR-155 (AUC 0.953), and miR-146a (AUC 0.903).
Conclusions:
- Altered circulating miRNA profiles are associated with immune response dysregulation in pediatric TB.
- miR-31, miR-155, and miR-146a show significant potential as reliable diagnostic biomarkers for active TB in children.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

